Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell membrane (more precisely, the **outer membrane**) of uropathogenic Escherichia coli and Salmonella Typhimurium is a defining feature of these Gram-negative pathogens. It is an asymmetric bilayer with an outer leaflet rich in lipopolysaccharide (LPS) and a periplasmic leaflet of phospholipids, containing numerous outer membrane proteins (Omps), porins (e.g., OmpC, OmpF, OmpA), transporters, structural polysaccharides, flagella, and fimbriae. This outer membrane acts as a permeability barrier, affords protection against antibiotics and host defenses, and plays a key role in virulence, nutrient uptake, and evasion of immune recognition. Its structural components, such as LPS, core oligosaccharides, and porins, are targets of some antibiotics and serve as key determinants of antigenicity and resistance[5][3][6][4][2]. **Note:** This entry refers to a whole cell structure, not to a singular, well-defined molecular target. For structured therapeutic targeting, subcomponents such as “lipopolysaccharide,” “OmpA,” “OmpC,” or “IroN siderophore receptor” should be considered as individual molecular targets[2][5].
Disruption of membrane integrity (e.g., polymyxins disrupt outer membrane LPS and phospholipids) Inhibition of cell wall synthesis (entry of beta-lactams via porins) Permeabilization to facilitate antibiotic entry
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli and Salmonella Typhimurium cell membrane.